Blog

Here’s why we must continue to study Kratom and other opioid-like drugs

The U.S. Food and Drug Administration (FDA) recently gave final approval for the first non-opioid drug shown to lessen the severity of opioid withdrawal symptoms. Meanwhile, President Trump signed into law groundbreaking “right to try” legislation allowing the terminally ill to explore unapproved medical treatments as a last resort.

In light of these developments, researchers and advocates of the botanical Kratom were hopeful for increased support for the study of the herb as a new treatment for opioid withdrawal symptoms, acute and chronic pain, and a range of mood disorders.

Read more:  http://thehill.com/opinion/healthcare/395944-heres-why-we-must-continue-to-study-kratom-and-other-opioid-like-drugs 

0

Leave a Reply

Your email address will not be published.